These included demographic characteristics (older age, male), clinical history (hypertension, diabetes mellitus, and hyperlipidemia), treatment status [receipt of percutaneous coronary intervention (PCI)], and routine laboratory parameters such as ALT, AST, LDL-C, creatinine, NT-proBNP, HDL-C, triglycerides, hemoglobin, and platelet count. This evidence concerns the gene NPPB and diabetes mellitus.